First developed as an accessible abridgement of the successful Handbook of Stem Cells, Essentials of Stem Cell Biology serves the needs of the evolving population of scientists, researchers, practitioners and students that are embracing the latest advances in stem cells. Representing the combined effort of seven editors and more than 200 scholars and scientists whose pioneering work has defined our understanding of stem cells, this book combines the prerequisites for a general understanding of adult and embryonic stem cells with a presentation by the world's experts of the latest research information about specific organ systems. From basic biology/mechanisms, early development, ectoderm, mesoderm, endoderm, methods to application of stem cells to specific human diseases, regulation and ethics, and patient perspectives, no topic in the field of stem cells is left uncovered.
- Selected for inclusion in Doody's Core Titles 2013, an essential collection development tool for health sciences libraries
- Contributions by Nobel Laureates and leading international investigators
- Includes two entirely new chapters devoted exclusively to induced pluripotent stem (iPS) cells written by the scientists who made the breakthrough
- Edited by a world-renowned author and researcher to present a complete story of stem cells in research, in application, and as the subject of political debate
- Presented in full color with glossary, highlighted terms, and bibliographic entries replacing references
Inhaltsverzeichnis
1;Front Cover;1 2;Essentials of Stem Cell Biology;4 3;Copyright Page;5 4;Contents;6 5;Contributors;10 6;Preface;16 7;Foreword;18 8;Why Stem Cell Research;20 9;A New Path: Induced Pluripotent Stem Cells;22 10;"Stemness": Definitions, Criteria, and Standards;24 11;Part I: Introduction to Stem Cells;32 11.1;Chapter 1. Pluripotential Stem Cells from Vertebrate Embryos: Present Perspective and Future Challenges;34 11.1.1;INTRODUCTION;34 11.1.2;TERMINOLOGY;35 11.1.3;ES-LIKE CELLS IN OTHER SPECIES;36 11.1.4;EMBRYONIC GERM CELLS;37 11.1.5;FUTURE CHALLENGES;38 11.1.6;BIOLOGY OF ES AND ES-LIKE CELLS;38 11.1.7;STEM CELL THERAPY;40 11.1.8;CONCLUSIONS;42 11.1.9;KEY WORDS;42 11.1.10;FURTHER READING;42 11.2;Chapter 2. Embryonic Stem Cells in Perspective;44 11.2.1;FURTHER READING;45 11.3;Chapter 3. The Development of Epithelial Stem Cell Concepts;48 11.3.1;INTRODUCTION;48 11.3.2;A DEFINITION OF STEM CELLS;49 11.3.3;HIERARCHICALLY ORGANIZED STEM CELL POPULATIONS;50 11.3.4;SKIN STEM CELLS;51 11.3.5;THE INTESTINAL STEM CELL SYSTEM;53 11.3.6;STEM CELL ORGANIZATION ON THE TONGUE;54 11.3.7;GENERALIZED SCHEME;55 11.3.8;SUMMARY;56 11.3.9;KEY WORDS;57 11.3.10;FURTHER READING;58 11.4;Chapter 4. Direct Reprogramming of Somatic Cells to a Pluripotent State;60 11.4.1;INTRODUCTION;60 11.4.2;KEY WORDS;62 11.4.3;FURTHER READING;62 11.5;Chapter 5. Clinical Translation of Stem Cells;64 11.5.1;INTRODUCTION;64 11.5.2;CELL PROCESSING AND MANUFACTURING;64 11.5.3;STUDIES WITH STEM CELLS IN ANIMAL MODELS;65 11.5.4;CLINICAL TRIALS WITH STEM CELLS IN PATIENTS;65 11.5.5;CONCLUSIONS;66 11.5.6;FURTHER READING;66 12;Part II: Basic Biology/Mechanisms;68 12.1;Chapter 6. Molecular Basis of Pluripotency;70 12.1.1;INTRODUCTION;70 12.1.2;CELLULAR MODELS OF PLURIPOTENCY;70 12.1.3;THE EMBRYONIC STEM CELL ENVIRONMENT: CYTOKINES AND PLURIPOTENCY;71 12.1.4;CYTOKINE-RECEPTOR BINDING ON ES CELLS: MULTIPLE RELAY STATIONS;72 12.1.5;SIGNAL TRANSDUCTION: CASCADES TO THE STEM CELL NUCLEUS;73 12.1.6;STATS: LATENT TRANSCRIPTION FA
CTORS TRANSMITTING SIGNALS;73 12.1.7;STAT3;74 12.1.8;SHP-2/ERK SIGNALING;75 12.1.9;FGF4 AND ERK;76 12.1.10;WNT SIGNALING;76 12.1.11;THE TGFβ SIGNALING PATHWAY;76 12.1.12;THE PI3K/AKT SIGNALING PATHWAY PARTICIPATES IN ES CELL PROLIFERATION, SURVIVAL, AND PLURIPOTENCY;77 12.1.13;THE NEW PARADIGM OF EMBRYONIC STEM CELL RENEWAL;78 12.1.14;INTRINSIC DETERMINANTS OF PLURIPOTENCY;79 12.1.15;OCT4 IS A KEY TRANSCRIPTION FACTOR FOR PLURIPOTENCY;79 12.1.16;OCT4 EXPRESSION;79 12.1.17;OCT4 ACTIVITY IN ASSAYS;80 12.1.18;REGULATION OF OCT4 EXPRESSION;81 12.1.19;OCT4 TARGET GENES;82 12.1.20;OCT4 DOES NOT PLAY SOLO: SOX2;82 12.1.21;FOXD3;84 12.1.22;NANOG;84 12.1.23;THE CORE TRANSCRIPTIONAL REGULATORY CIRCUITRY CONTROLLING ES CELL IDENTITY;86 12.1.24;THE ROLE OF MICRO-RNAS IN PLURIPOTENCY;86 12.1.25;DGCR8;87 12.1.26;THE CHROMATIN STATUS DEFINING STEM CELL IDENTITY;87 12.1.27;REPROGRAMMING OF SOMATIC CELLS TO A PLURIPOTENT STATE: IPS VERSUS ES;88 12.1.28;CONCLUSIONS;89 12.1.29;KEY TERMS;90 12.1.30;FURTHER READING;90 12.2;Chapter 7. Stem Cell Niches;92 12.2.1;INTRODUCTION;92 12.2.2;STEM CELL NICHE HYPOTHESIS;92 12.2.3;STEM CELL NICHES IN THE DROSOPHILA GERMLINE;92 12.2.4;STEM CELL NICHES WITHIN MAMMALIAN TISSUES;96 12.2.5;SUMMARY;101 12.2.6;ACKNOWLEDGMENTS;102 12.2.7;KEY WORDS;103 12.2.8;FURTHER READING;103 12.3;Chapter 8. Mechanisms of Stem Cell Self-renewal;104 12.3.1;INTRODUCTION;104 12.3.2;SELF-RENEWAL OF PLURIPOTENT STEM CELLS;104 12.3.3;MOLECULAR MECHANISM FOR RETENTION OF EMBRYONIC STEM CELL SELF-RENEWAL;105 12.3.4;EPIGENETIC REGULATION OF SELF-RENEWAL;109 12.3.5;SELF-RENEWAL OF HUMAN EMBRYONIC STEM CELLS;110 12.3.6;SUMMARY;110 12.3.7;KEY WORDS;110 12.3.8;FURTHER READING;110 12.4;Chapter 9. Cell Cycle Regulators in Adult Stem Cells;112 12.4.1;INTRODUCTION;112 12.4.2;CELL CYCLE KINETICS OF STEM CELLS IN VIVO;112 12.4.3;STEM CELL EXPANSION EX VIVO;113 12.4.4;MAMMALIAN CELL CYCLE REGULATION AND CYCLIN-DEPENDENT KINASE INHIBITORS;113 12.4.5;ROLES OF CYCLIN-DEPENDENT KINASE INHI
BITORS IN STEM CELL REGULATION;114 12.4.6;SUMMARY;117 12.4.7;ACKNOWLEDGMENTS;117 12.4.8;KEY WORDS;117 12.4.9;FURTHER READING;117 12.5;Chapter 10. Epigenetic Mechanisms of Cellular Memory during Development;120 12.5.1;INTRODUCTION;120 12.5.2;CHROMATIN-MODIFYING FACTORS;123 12.5.3;ATPASE CHROMATIN-REMODELING COMPLEXES;125 12.5.4;EPIGENETIC PROCESSES;126 12.5.5;X-CHROMOSOME INACTIVATION;128 12.5.6;MONOALLELIC EXPRESSION: GENOMIC IMPRINTING AND ALLELIC EXCLUSION;131 12.5.7;SUMMARY AND FUTURE DIRECTIONS;133 12.5.8;KEY WORDS;134 12.5.9;FURTHER READING;134 12.6;Chapter 11. Cell Fusion and the Differentiated State;136 12.6.1;INTRODUCTION;136 12.6.2;HYBRID CELLS AND DIFFERENTIATED PHENOTYPES;136 12.6.3;HYBRIDS OF PLURIPOTENT CELLS;137 12.6.4;REPROGRAMMING SOMATIC CELL NUCLEI WITH EC, ES, OR EG CELL CYTOPLASM;138 12.6.5;CELL FUSION AND THE DEMONSTRATION OF STEM CELL PLASTICITY;139 12.6.6;SUMMARY;140 12.6.7;ACKNOWLEDGMENTS;140 12.6.8;KEY WORDS;140 12.6.9;FURTHER READING;141 12.7;Chapter 12. How Cells Change Their Phenotype;142 12.7.1;INTRODUCTION;142 12.7.2;METAPLASIA AND TRANSDIFFERENTIATION;142 12.7.3;WHY STUDY TRANSDIFFERENTIATION?;142 12.7.4;EXAMPLES OF THE PHENOMENON;142 12.7.5;DEDIFFERENTIATION AS A PREREQUISITE FOR TRANSDIFFERENTIATION;145 12.7.6;HOW TO CHANGE A CELL'S PHENOTYPE EXPERIMENTALLY;146 12.7.7;SUMMARY;147 12.7.8;ACKNOWLEDGMENTS;147 12.7.9;KEY WORDS;147 12.7.10;FURTHER READING;147 13;Part III: Tissue and Organ Development;148 13.1;Chapter 13. Differentiation in Early Development;150 13.1.1;INTRODUCTION;150 13.1.2;PRE-IMPLANTATION DEVELOPMENT;150 13.1.3;FROM IMPLANTATION TO GASTRULATION;156 13.1.4;ACKNOWLEDGMENTS;160 13.1.5;KEY WORDS;160 13.1.6;FURTHER READING;160 13.2;Chapter 14. Primordial Germ Cells in Mouse and Human;162 13.2.1;INTRODUCTION;162 13.2.2;ORIGIN OF THE GERM CELL LINEAGE;162 13.2.3;MIGRATION;164 13.2.4;GERM CELLS IN THE GENITAL RIDGE;164 13.2.5;EMBRYONIC GERM CELLS;166 13.2.6;SUMMARY;166 13.2.7;KEY WORDS;167 13.2.8;FURTHER READING;167 13.3;Chapt
er 15. Stem Cells in Extraembryonic Lineages;168 13.3.1;INTRODUCTION;168 13.3.2;TROPHOBLAST LINEAGE;168 13.3.3;TROPHOBLAST STEM CELL LINES;172 13.3.4;EXTRAEMBRYONIC ENDODERM LINEAGE;174 13.3.5;SUMMARY;175 13.3.6;KEY WORDS;175 13.3.7;FURTHER READING;175 13.4;Chapter 16. Amniotic Fluid-Derived Pluripotential Cells;176 13.4.1;INTRODUCTION;176 13.4.2;AMNIOTIC FLUID AND AMNIOCENTESIS;176 13.4.3;ISOLATION AND CHARACTERIZATION OF PROGENITOR CELLS;177 13.4.4;DIFFERENTIATION POTENTIAL OF AMNIOTIC PROGENITOR CELLS;177 13.4.5;IN VIVO BEHAVIOR OF AMNIOTIC FLUID STEM CELLS;180 13.4.6;FUTURE DIRECTIONS;180 13.4.7;SUMMARY;180 13.4.8;KEY WORDS;181 13.4.9;FURTHER READING;181 13.5;Chapter 17. Cord Blood Hematopoietic Stem and Progenitor Cells;182 13.5.1;INTRODUCTION;182 13.5.2;CHARACTERISTICS AND CRYOPRESERVATION OF CORD BLOOD STEM AND PROGENITOR CELLS;182 13.5.3;CORD BLOOD TRANSPLANTATION PROBLEMS AND POSSIBLE COUNTERMEASURES;183 13.5.4;HOMING OF STEM AND PROGENITOR CELLS;185 13.5.5;SUMMARY;186 13.5.6;KEY WORDS;186 13.5.7;FURTHER READING;186 13.6;Chapter 18. Neurogenesis in the Vertebrate Embryo;188 13.6.1;INTRODUCTION;188 13.6.2;EMBRYONIC INDUCTION AND THE ESTABLISHMENT OF NEURAL TISSUE;188 13.6.3;MOLECULAR BASES OF NEURAL INDUCTION;188 13.6.4;NEURAL PATTERNING;191 13.6.5;PRONEURAL GENE EXPRESSION;195 13.6.6;NEGATIVE REGULATORS OF PRONEURAL ACTIVITY;195 13.6.7;REGULATION OF NEURONAL DIFFERENTIATION BY REST/NRSF;197 13.6.8;SWITCH FROM NEUROGENESIS TO GLIOGENESIS;197 13.6.9;SUMMARY;197 13.6.10;KEY WORDS;198 13.6.11;FURTHER READING;198 13.7;Chapter 19. The Nervous System;200 13.7.1;INTRODUCTION;200 13.7.2;NEURAL DEVELOPMENT;200 13.7.3;NEURAL STEM CELLS;201 13.7.4;NEURAL DIFFERENTIATION OF MOUSE EMBRYONIC STEM CELLS;201 13.7.5;NEURAL DIFFERENTIATION OF HUMAN AND NONHUMAN PRIMATE ES CELLS;206 13.7.6;DEVELOPMENTAL PERSPECTIVE;207 13.7.7;THERAPEUTIC PERSPECTIVES;207 13.7.8;CONCLUSION;208 13.7.9;KEY WORDS;209 13.7.10;FURTHER READING;209 13.8;Chapter 20. Neuronal Progenitors in the Adult Br
ain: From Development to Regulation;210 13.8.1;INTRODUCTION;210 13.8.2;HISTORY OF STEM CELLS IN THE ADULT CENTRAL NERVOUS SYSTEM;210 13.8.3;GLIAL CHARACTERISTICS OF NEURAL STEM CELLS;210 13.8.4;ADULT NEUROGENESIS IN VIVO;211 13.8.5;SUMMARY;213 13.8.6;KEY WORDS;213 13.8.7;FURTHER READING;213 13.9;Chapter 21. Sensory Epithelium of the Eye and Ear: Update of Retinal Stem Cell Research 2003 to the Present;216 13.9.1;INTRODUCTION;216 13.9.2;MUELLER GLIA AS A SOURCE OF NEW RETINAL NEURONS;216 13.9.3;EMBRYONIC STEM CELLS AS A SOURCE OF RETINAL NEURONS;217 13.9.4;KEY WORDS;218 13.9.5;FURTHER READING;219 13.10;Chapter 22. Epithelial Hair Follicle Stem Cells;220 13.10.1;INTRODUCTION;220 13.10.2;A BRIEF INTRODUCTION TO MOUSE SKIN ORGANIZATION;220 13.10.3;THE BULGE AS A RESIDENCE OF HAIR FOLLICLE STEM CELLS;222 13.10.4;MODELS OF HAIR FOLLICLE STEM CELL ACTIVATION;224 13.10.5;MOLECULAR FINGERPRINT OF THE BULGE: PUTATIVE STEM CELL MARKERS;225 13.10.6;CELL SIGNALING IN HAIR FOLLICLE STEM CELLS;226 13.10.7;COMMENTARY AND FUTURE DIRECTIONS;227 13.10.8;KEY WORDS;228 13.10.9;FURTHER READING;228 13.11;Chapter 23. The Ontogeny of the Hematopoietic System;230 13.11.1;HISTORIC PERSPECTIVE;230 13.11.2;SITES OF INITIATION OF PRIMITIVE AND DEFINITIVE HEMATOPOIESIS AND VASCULOGENESIS;230 13.11.3;STEM CELL MIGRATION TO LATER SITES OF HEMATOPOIESIS;236 13.11.4;CELL MIGRATION TO PRIMARY LYMPHOID ORGANS;237 13.11.5;KEY WORDS;240 13.11.6;FURTHER READING;240 13.12;Chapter 24. Hematopoietic Stem Cells;242 13.12.1;EMBRYONIC STEM CELLS AND EMBRYONIC HEMATOPOIESIS;242 13.12.2;BLOOD FORMATION IN EMBRYOID BODIES;243 13.12.3;TRANSFORMATION OF AN EB-DERIVED HSC BY BCR/ABL;243 13.12.4;PROMOTING HEMATOPOIETIC ENGRAFTMENT WITH STAT5 AND HOXB4;243 13.12.5;PROMOTING BLOOD FORMATION IN VITRO WITH EMBRYONIC MORPHOGENS;245 13.12.6;KEY WORDS;245 13.12.7;FURTHER READING;246 13.13;Chapter 25. Red Blood Cells;248 13.13.1;ERYTHROPOIESIS;248 13.13.2;ERYTHROCYTES GENERATED FROM ADULT STEM CELLS IN VITRO;248 13.13.3;ERYTH
ROCYTES GENERATED FROM MOUSE EMBRYONIC STEM CELLS;249 13.13.4;ERYTHROCYTES GENERATED FROM HUMAN EMBRYONIC STEM CELLS;249 13.13.5;ENUCLEATION OF ERYTHROID CELLS;252 13.13.6;SUMMARY;253 13.13.7;KEY WORDS;253 13.13.8;FURTHER READING;253 13.14;Chapter 26. Cell Differentiation in the Skeleton;254 13.14.1;INTRODUCTION;254 13.14.2;SKELETOGENESIS;254 13.14.3;CHONDROCYTE DIFFERENTIATION;255 13.14.4;OSTEOBLAST DIFFERENTIATION;256 13.14.5;KEY WORDS;257 13.14.6;FURTHER READING;257 13.15;Chapter 27. Human Vascular Progenitor Cells;258 13.15.1;HUMAN VASCULAR DEVELOPMENT, MAINTENANCE AND RENEWAL;258 13.15.2;HUMAN EMBRYONIC STEM CELLS AS A SOURCE FOR VASCULAR PROGENITORS;260 13.15.3;ACKNOWLEDGMENTS;263 13.15.4;KEY WORDS;263 13.15.5;FURTHER READING;263 13.16;Chapter 28. Multipotent Adult Progenitor Cells;264 13.16.1;INTRODUCTION;264 13.16.2;ISOLATION AND PHENOTYPIC CHARACTERIZATION OF MULTIPOTENT ADULT PROGENITOR CELLS;264 13.16.3;IN VITRO DIFFERENTIATION POTENTIAL OF MULTIPOTENT ADULT PROGENITOR CELLS;265 13.16.4;IN VIVO ENGRAFTMENT OF MULTIPOTENT ADULT PROGENITOR CELLS;266 13.16.5;MULTIPOTENT ADULT PROGENITOR CELLS IN ISCHEMIA MODELS;266 13.16.6;SYSTEMIC TRANSPLANTATION OF MULTIPOTENT ADULT PROGENITOR CELLS;267 13.16.7;OTHER ADULT STEM CELLS WITH GREATER DIFFERENTIATION POTENTIAL;268 13.16.8;POSSIBLE MECHANISMS UNDERLYING THE GREATER POTENCY OF MULTIPOTENT ADULT PROGENITOR CELLS;268 13.16.9;KEY WORDS;270 13.16.10;FURTHER READING;271 13.17;Chapter 29. Mesenchymal Stem Cells;274 13.17.1;INTRODUCTION;274 13.17.2;TISSUE-ENGINEERED REGENERATION;276 13.17.3;ISOLATING AND CULTURING MESENCHYMAL STEM CELLS;277 13.17.4;TISSUE-ENGINEERING USES OF MESENCHYMAL STEM CELLS;277 13.17.5;SUMMARY;279 13.17.6;ACKNOWLEDGMENTS;279 13.17.7;KEY WORDS;279 13.17.8;FURTHER READING;279 13.18;Chapter 30. Skeletal Muscle Stem Cells;280 13.18.1;INTRODUCTION;280 13.18.2;SATELLITE CELLS IDENTIFICATION;280 13.18.3;SATELLITE CELL HETEROGENEITY;282 13.18.4;SATELLITE CELL SELF-RENEWAL;283 13.18.5;INTRINSIC REGULATION
OF SATELLITE CELLS;284 13.18.6;EXTRINSIC REGULATION OF SATELLITE CELLS;285 13.18.7;SUMMARY;288 13.18.8;ACKNOWLEDGMENTS;288 13.18.9;KEY WORDS;288 13.18.10;FURTHER READING;288 13.19;Chapter 31. Stem Cells and the Regenerating Heart;290 13.19.1;INTRODUCTION;290 13.19.2;EVOLVING CONCEPTS OF REGENERATION;292 13.19.3;ACKNOWLEDGMENTS;294 13.19.4;KEY WORDS;294 13.19.5;FURTHER READING;294 13.20;Chapter 32. Potential of Embryonic and Induced Pluripotent Stem Cell Differentiation Culture for Vascular Biology;296 13.20.1;INTRODUCTION;296 13.20.2;CULTURES FOR EMBRYONIC STEM CELL DIFFERENTIATION;296 13.20.3;MARKERS FOR DEFINING INTERMEDIATE STAGES DURING ENDOTHELIAL CELL DIFFERENTIATION;297 13.20.4;UTILITY OF EMBRYONIC STEM CELL CULTURE FOR CELL BIOLOGY OF ENDOTHELIAL CELLS;298 13.20.5;ENDOTHELIAL CELL DIVERSIFICATION;299 13.20.6;CONCLUDING REMARKS;301 13.20.7;KEY WORDS;302 13.20.8;FURTHER READING;302 13.21;Chapter 33. Cell Lineages and Stem Cells in the Embryonic Kidney;304 13.21.1;INTRODUCTION;304 13.21.2;THE ANATOMY OF KIDNEY DEVELOPMENT;304 13.21.3;GENES THAT CONTROL EARLY KIDNEY DEVELOPMENT;307 13.21.4;THE ESTABLISHMENT OF ADDITIONAL CELL LINEAGES;310 13.21.5;WHAT CONSTITUTES A RENAL STEM CELL?;312 13.21.6;ACKNOWLEDGMENTS;313 13.21.7;KEY WORDS;313 13.21.8;FURTHER READING;313 13.22;Chapter 34. Adult Liver Stem Cells;316 13.22.1;INTRODUCTION;316 13.22.2;ORGANIZATION AND FUNCTIONS OF ADULT MAMMALIAN LIVER;316 13.22.3;LIVER STEM CELLS;317 13.22.4;IMMORTAL LIVER PROGENITOR CELL LINES;323 13.22.5;KEY WORDS;329 13.22.6;FURTHER READING;329 13.23;Chapter 35. Pancreatic Stem Cells;330 13.23.1;INTRODUCTION;330 13.23.2;DEFINITION OF STEM CELLS AND OF PROGENITOR CELLS;330 13.23.3;PROGENITOR CELLS DURING EMBRYONIC DEVELOPMENT OF THE PANCREAS;331 13.23.4;PROGENITOR CELLS IN THE ADULT PANCREAS;332 13.23.5;FORCING OTHER TISSUES TO ADOPT A PANCREATIC PHENOTYPE;334 13.23.6;IN VITRO STUDIES;335 13.23.7;SUMMARY;336 13.23.8;KEY WORDS;336 13.23.9;FURTHER READING;336 13.24;Chapter 36. Stem Cells i
n the Gastrointestinal Tract;338 13.24.1;INTRODUCTION;338 13.24.2;GASTROINTESTINAL MUCOSA CONTAINS MULTIPLE LINEAGES;339 13.24.3;EPITHELIAL CELL LINEAGES ORIGINATE FROM A COMMON PRECURSOR CELL;339 13.24.4;SINGLE INTESTINAL STEM CELLS REGENERATE WHOLE CRYPTS CONTAINING ALL EPITHELIAL LINEAGES;340 13.24.5;MOUSE AGGREGATION CHIMERAS SHOW THAT INTESTINAL CRYPTS ARE CLONAL POPULATIONS;340 13.24.6;SOMATIC MUTATIONS IN STEM CELLS REVEAL STEM CELL HIERARCHY AND CLONAL SUCCESSION;341 13.24.7;HUMAN INTESTINAL CRYPTS CONTAIN MULTIPLE EPITHELIAL CELL LINEAGES DERIVED FROM A SINGLE STEM CELL;344 13.24.8;BONE MARROW STEM CELLS CONTRIBUTE TO GUT REPOPULATION AFTER DAMAGE;345 13.24.9;GASTROINTESTINAL STEM CELLS OCCUPY A NICHE MAINTAINED BY INTESTINAL SUBEPITHELIAL MYOFIBROBLASTS IN THE LAMINA PROPRIA;348 13.24.10;MANY SIGNALING PATHWAYS REGULATE GASTROINTESTINAL DEVELOPMENT, PROLIFERATION, AND DIFFERENTIATION;350 13.24.11;WNT/β-CATENIN SIGNALING PATHWAY MAINTAINS THE PROLIFERATIVE COMPARTMENT OF INTESTINAL CRYPTS;350 13.24.12;WNT TARGETS EPHB DETERMINE CELL POSITIONING ALONG THE CRYPT AXIS;351 13.24.13;NOTCH SIGNALING IS ALSO TO MAINTAIN THE PROLIFERATIVE COMPARTMENT OF INTESTINAL CRYPTS, AND DETERMINES CELL FATE;352 13.24.14;BONE MORPHOGENIC PATHWAY SIGNALING REGULATES PROLIFERATION ALONG THE INTESTINAL CRYPT AXIS;353 13.24.15;HEDGEHOG SIGNALING PATTERNS THE CRYPT AXIS;353 13.24.16;HOX GENES DEFINE REGIONAL GUT SPECIFICATION;353 13.24.17;GASTROINTESTINAL NEOPLASMS ORIGINATE IN STEM CELL POPULATIONS;353 13.24.18;SUMMARY;357 13.24.19;KEY WORDS;357 13.24.20;FURTHER READING;358 14;Part IV: Methods;360 14.1;Chapter 37. Induced Pluripotent Stem Cell Derivation;362 14.1.1;INTRODUCTION;362 14.1.2;MATERIALS;362 14.1.3;PREPARING TRANSGENE-EXPRESSING LENTIVIRUS;363 14.1.4;REPROGRAMMING HUMAN FORESKIN FIBROBLASTS;366 14.1.5;ACKNOWLEDGMENTS;368 14.1.6;KEY WORDS;368 14.1.7;FURTHER READING;368 14.2;Chapter 38. Characteristics and Characterization of Human Pluripotent Stem Cells;370 14.2.1;I
NTRODUCTION;370 14.2.2;CHARACTERIZATION OF PLURIPOTENT CELLS;372 14.2.3;SUMMARY;373 14.2.4;KEY WORDS;374 14.2.5;FURTHER READING;374 14.3;Chapter 39. Isolation and Maintenance of Murine Embryonic Stem Cells;376 14.3.1;INTRODUCTION;376 14.3.2;MAINTENANCE OF EMBRYONIC STEM CELLS;376 14.3.3;MEDIA;377 14.3.4;SERA;377 14.3.5;COLONY-FORMING ASSAY FOR TESTING CULTURE CONDITIONS;377 14.3.6;EMBRYONIC STEM CELL PASSAGE CULTURE;378 14.3.7;ISOLATION OF NEW EMBRYONIC STEM CELL LINES;378 14.3.8;METHOD FOR DERIVATION OF EMBRYONIC STEM CELLS;379 14.3.9;SUMMARY;380 14.3.10;FURTHER READING;380 14.4;Chapter 40. Isolation, Characterization and Maintenance of Primate Embryonic Stem Cells;382 14.4.1;INTRODUCTION;382 14.4.2;WHAT ARE PRIMATE EMBRYONIC STEM CELLS?;383 14.4.3;TECHNIQUES FOR THE DERIVATION OF HUMAN EMBRYONIC STEM CELL LINES;384 14.4.4;DERIVATION OF HUMAN EMBRYONIC STEM CELL SUBCLONES;388 14.4.5;METHODS FOR HUMAN EMBRYONIC STEM CELL CULTURE;389 14.4.6;PRIMATE VERSUS MOUSE EMBRYONIC STEM CELLS;391 14.4.7;PRIMATE EMBRYONIC STEM CELL DIFFERENTIATION SYSTEMS;393 14.4.8;ACKNOWLEDGMENTS;393 14.4.9;FURTHER READING;393 14.5;Chapter 41. Approaches for Derivation and Maintenance of Human Embryonic Stem Cells: Detailed Procedures and Alternatives;396 14.5.1;INTRODUCTION;396 14.5.2;SETTING UP THE LABORATORY;396 14.5.3;PREPARING AND SCREENING REAGENTS;397 14.5.4;PREPARING PRIMARY MOUSE EMBRYO FIBROBLAST (PMEF) FEEDERS;400 14.5.5;MECHANICAL PASSAGING OF HUMAN EMBRYONIC STEM CELL COLONIES;400 14.5.6;DERIVATION OF HUMAN EMBRYONIC STEM CELLS;402 14.5.7;MAINTENANCE OF ESTABLISHED HUMAN EMBRYONIC STEM CELL CULTURES;403 14.5.8;GLOSSARY TERMS;409 14.5.9;FURTHER READING;409 14.6;Chapter 42. Derivation and Differentiation of Human Embryonic Germ Cells;412 14.6.1;INTRODUCTION;412 14.6.2;HUMAN EMBRYONIC GERM CELL DERIVATION;413 14.6.3;EMBRYOID BODY-DERIVED CELLS;418 14.6.4;SUMMARY;421 14.6.5;KEY WORDS;421 14.6.6;FURTHER READING;421 14.7;Chapter 43. Growth Factors and the Serum-free Culture of Human Plu
ripotent Stem Cells;422 14.7.1;INTRODUCTION;422 14.7.2;MOUSE EMBRYONIC STEM CELLS;422 14.7.3;HUMAN EMBRYONAL CARCINOMA CELLS;423 14.7.4;HUMAN EMBRYONIC STEM CELLS;423 14.7.5;EXTRACELLULAR MATRIX COMPONENTS;425 14.7.6;FUTURE PROSPECTS;425 14.7.7;KEY WORDS;426 14.7.8;FURTHER READING;426 14.8;Chapter 44. Feeder-free Culture;428 14.8.1;INTRODUCTION;428 14.8.2;FEEDER-FREE CULTURE USING CONDITIONED MEDIUM AND MATRIGEL;428 14.8.3;FEEDER-FREE CULTURE USING CONDITIONED MEDIUM AND MATRIGEL OR LAMININ;431 14.8.4;FEEDER-FREE CULTURE USING DEFINED MEDIA AND MATRIGEL;432 14.8.5;MATERIALS FOR FEEDER-FREE HUMAN EMBRYONIC STEM CELL CULTURE;436 14.8.6;KEY WORDS;438 14.8.7;FURTHER READING;438 14.9;Chapter 45. Genetic Manipulation of Human Embryonic Stem Cells;440 14.9.1;INTRODUCTION;440 14.9.2;METHODS OF GENETIC MANIPULATION;440 14.9.3;GENETIC MODIFICATION APPROACHES;441 14.9.4;CONCLUSIONS;446 14.9.5;KEY WORDS;446 14.9.6;FURTHER READING;446 14.10;Chapter 46. Homologous Recombination in Human Embryonic Stem Cells;448 14.10.1;INTRODUCTION;448 14.10.2;TARGETED ABLATION OF THE HPRT1 GENE AS A TOOL TO OPTIMIZE HOMOLOGOUS RECOMBINATION EFFICIENCY;448 14.10.3;OCT4 EGFP/NEO KNOCKIN;450 14.10.4;TH EGFP KNOCKIN;451 14.10.5;CONCLUSIONS;452 14.10.6;ACKNOWLEDGMENTS;452 14.10.7;KEY WORDS;452 14.10.8;FURTHER READING;453 14.11;Chapter 47. Surface Antigen Markers;454 14.11.1;INTRODUCTION;454 14.11.2;CELL-SURFACE EMBRYONIC ANTIGENS OF THE LABORATORY MOUSE;454 14.11.3;HUMAN EMBRYONAL CARCINOMA AND EMBRYONIC STEM CELLS;455 14.11.4;SUMMARY;456 14.11.5;APPENDIX: METHODS;457 14.11.6;NOTES;458 14.11.7;SOLUTIONS AND NOTES;458 14.11.8;ACKNOWLEDGMENTS;459 14.11.9;KEY WORDS;459 14.11.10;FURTHER READING;459 14.12;Chapter 48. Lineage Marking;460 14.12.1;DEFINITIONS;460 14.12.2;QUESTIONS TO ASK;460 14.12.3;MARKERS AND LINEAGE MARKING;461 14.12.4;FUTURE DIRECTIONS;466 14.12.5;ACKNOWLEDGMENTS;466 14.12.6;KEY WORDS;466 14.12.7;FURTHER READING;466 14.13;Chapter 49. Genomic Reprogramming;468 14.13.1;INTRODUCTION;468 14.
13.2;GENOMIC REPROGRAMMING IN GERM CELLS;468 14.13.3;REPROGRAMMING SOMATIC NUCLEI;472 14.13.4;CONCLUSIONS;472 14.13.5;KEY WORDS;473 14.13.6;FURTHER READING;473 14.14;Chapter 50. Isolation and Characterization of Hematopoietic Stem Cells;474 14.14.1;INTRODUCTION;474 14.14.2;ISOLATION OF HEMATOPOIETIC STEM CELLS FROM MICE;474 14.14.3;ISOLATION OF HEMATOPOIETIC STEM CELLS FROM HUMANS;477 14.14.4;HEMATOPOIETIC STEM CELLS AS A PARADIGM FOR STEM CELL BIOLOGY;478 14.14.5;ACKNOWLEDGMENT;478 14.14.6;KEY WORDS;478 14.14.7;FURTHER READING;478 14.15;Chapter 51. Microarray Analysis of Stem Cells and Differentiation;480 14.15.1;INTRODUCTION;480 14.15.2;KEY WORDS;487 14.15.3;FURTHER READING;488 14.16;Chapter 52. Zebrafish and Stem Cell Research;490 14.16.1;INTRODUCTION;490 14.16.2;THE ZEBRAFISH SYSTEM;490 14.16.3;GENETIC SCREENS IN ZEBRAFISH;492 14.16.4;ZEBRAFISH BLOOD MUTANTS;493 14.16.5;CELL SORTING AND TRANSPLANTATION;494 14.16.6;DISEASE MODELS IN ZEBRAFISH;495 14.16.7;THE FUTURE OF THE SYSTEM;495 14.16.8;ACKNOWLEDGMENTS;496 14.16.9;KEY WORDS;496 14.16.10;FURTHER READING;496 15;Part V: Applications;498 15.1;Chapter 53. Cancer Stem Cells;500 15.1.1;INTRODUCTION;500 15.1.2;CLONALITY AND HETEROGENEITY IN TUMORS;500 15.1.3;THE CANCER STEM CELL MODEL;501 15.1.4;DEFINING FEATURES OF STEM CELLS IN NORMAL TISSUES;502 15.1.5;NOT ALL CANCER CELLS ARE TUMORIGENIC: CLINICAL AND EXPERIMENTAL EVIDENCE;503 15.1.6;SOME CANCERS CAN DIFFERENTIATE INTO NONMALIGNANT CELLS;504 15.1.7;EVIDENCE SUPPORTING THE CANCER STEM CELL MODEL: PROSPECTIVE ISOLATION OF CANCER STEM CELLS;504 15.1.8;ORIGINS OF CANCER STEM CELLS: THE PLASTICITY OF SELF-RENEWAL;507 15.1.9;SIGNALING PATHWAYS IN CANCER STEM CELLS;508 15.1.10;CLINICAL IMPLICATIONS OF CANCER STEM CELLS;509 15.1.11;FUTURE DIRECTIONS;510 15.1.12;FURTHER READING;510 15.2;Chapter 54. Neural Stem Cells for Central Nervous System Repair;516 15.2.1;INTRODUCTION;516 15.2.2;THERAPEUTIC POTENTIAL OF NEURAL STEM CELLS;516 15.2.3;GENE THERAPY USING NEURAL STEM CELL
S;520 15.2.4;CELL REPLACEMENT USING NEURAL STEM CELLS;521 15.2.5;"GLOBAL" CELL REPLACEMENT USING NEURAL STEM CELLS;521 15.2.6;NEURAL STEM CELLS DISPLAY AN INHERENT MECHANISM FOR RESCUING DYSFUNCTIONAL NEURONS;523 15.2.7;NEURAL STEM CELLS AS THE GLUE THAT HOLDS MULTIPLE THERAPIES TOGETHER;525 15.2.8;SUMMARY;525 15.2.9;KEY WORDS;527 15.2.10;FURTHER READING;527 15.3;Chapter 55. Spinal Cord Injury;528 15.3.1;INTRODUCTION;528 15.3.2;PROBLEM;528 15.3.3;SPINAL CORD ORGANIZATION;528 15.3.4;INJURY;528 15.3.5;SPONTANEOUS REGENERATION;529 15.3.6;LIMITATIONS AND APPROACHES TO REPAIR AND REDEFINING GOALS;529 15.3.7;SPINAL CORD DEVELOPMENT;530 15.3.8;EMBRYONIC STEM CELLS;531 15.3.9;EMBRYONIC STEM CELLS AND THE NEURAL LINEAGE;531 15.3.10;EMBRONIC STEM CELL TRANSPLANTATION;531 15.3.11;NOVEL APPROACHES TO CENTRAL NERVOUS SYSTEM REPAIR;536 15.3.12;TOWARD HUMAN TRIALS;537 15.3.13;SUMMARY;537 15.3.14;KEY WORDS;537 15.3.15;FURTHER READING;537 15.4;Chapter 56. Use of Embryonic Stem Cells to Treat Heart Disease;538 15.4.1;INTRODUCTION;538 15.4.2;CARDIOMYOCYTE TRANSPLANTATION AS A PARADIGM FOR THE TREATMENT OF DISEASED HEARTS;538 15.4.3;EMBRYONIC STEM CELL-DERIVED CARDIOMYOCYTES, AND FACTORS WHICH ENHANCE CARDIOMYOGENIC DIFFERENTIATION;539 15.4.4;TRANSPLANTATION OF EMBRYONIC STEM CELL-DERIVED CARDIOMYOCYTES IN PRECLINICAL STUDIES, AND CHALLENGES FOR THEIR CLINICAL IMPLEMENTATION;540 15.4.5;SUMMARY;543 15.4.6;ACKNOWLEDGMENTS;543 15.4.7;KEY WORDS;543 15.4.8;FURTHER READING;543 15.5;Chapter 57. Insulin-producing Cells Derived from Stem Cells: A Potential Treatment for Diabetes;544 15.5.1;THE NEED FOR INSULIN-PRODUCING CELLS;544 15.5.2;DEFINING β-CELLS, STEM CELLS, AND PROGENITOR CELLS;544 15.5.3;THE POTENTIAL OF EMBRYONIC STEM CELLS AS A SOURCE OF INSULIN-PRODUCING CELLS;545 15.5.4;THE POTENTIAL OF ADULT STEM/PROGENITOR CELLS AS A SOURCE OF INSULIN-PRODUCING CELLS;547 15.5.5;TRANSDIFFERENTIATION OF NON-ISLET CELLS TO ISLET CELLS;550 15.5.6;CONCLUSION ON ADULT SOURCES OF NEW ISLET CELLS;5
51 15.5.7;ACKNOWLEDGMENTS;551 15.5.8;KEY WORDS;551 15.5.9;FURTHER READING;552 15.6;Chapter 58. Burns and Skin Ulcers;554 15.6.1;INTRODUCTION;554 15.6.2;BURNS AND SKIN ULCERS: THE PROBLEM;554 15.6.3;EPIDERMAL STEM CELLS;554 15.6.4;STEM CELLS IN BURNS AND SKIN ULCERS: CURRENT USE;555 15.6.5;FUTURE DEVELOPMENTS;557 15.6.6;SUMMARY;558 15.6.7;ACKNOWLEDGMENTS;559 15.6.8;KEY WORDS;559 15.6.9;FURTHER READING;559 15.7;Chapter 59. Stem Cells and Heart Disease;560 15.7.1;THE HEART IS A SELF-RENEWING ORGAN;560 15.7.2;THE HUMAN HEART CONTAINS A POOL OF RESIDENT CARDIAC PROGENITOR CELLS;561 15.7.3;ANATOMICAL DISTRIBUTION OF CARDIAC PROGENITOR CELLS;565 15.7.4;REPAIR OF MYOCARDIAL DAMAGE BY NON-RESIDENT PROGENITOR CELLS;566 15.7.5;REPAIR OF MYOCARDIAL DAMAGE BY RESIDENT PROGENITOR CELLS;568 15.7.6;MYOCARDIAL REGENERATION IN HUMANS;572 15.7.7;KEY WORDS;573 15.7.8;FURTHER READING;573 15.8;Chapter 60. Stem Cells for the Treatment of Muscular Dystropy: Therapeutic Perspectives;574 15.8.1;INTRODUCTION;574 15.8.2;MYOBLAST TRANSPLANTATION: REASONS FOR FAILURE AND NEW PERSPECTIVES;575 15.8.3;MYOGENIC STEM CELLS IN THE BONE MARROW AND BONE MARROW TRANSPLANTATION;575 15.8.4;CELLULAR ENVIRONMENT OF A DYSTROPHIC MUSCLE: RESIDENT AND MIGRATORY CELLS;578 15.8.5;FUTURE PERSPECTIVES;579 15.8.6;ACKNOWLEDGMENTS;579 15.8.7;KEY WORDS;579 15.8.8;FURTHER READING;580 15.9;Chapter 61. Regeneration of Epidermis from Adult Keratinocyte Stem Cells;582 15.9.1;INTRODUCTION;582 15.9.2;FUTURE DEVELOPMENT;590 15.9.3;SUMMARY;590 15.9.4;ACKNOWLEDGMENTS;590 15.9.5;KEY WORDS;590 15.9.6;FURTHER READING;591 15.10;Chapter 62. Orthopedic Applications of Stem Cells;592 15.10.1;INTRODUCTION;592 15.10.2;BONE;593 15.10.3;CARTILAGE;594 15.10.4;MENISCUS;596 15.10.5;LIGAMENTS AND TENDONS;597 15.10.6;SPINE;599 15.10.7;SUMMARY;600 15.10.8;KEY WORDS;600 15.10.9;FURTHER READING;600 15.11;Chapter 63. Embryonic Stem Cells in Tissue Engineering;602 15.11.1;INTRODUCTION;602 15.11.2;TISSUE ENGINEERING PRINCIPLES AND PERSPECTIVES;602 15
.11.3;LIMITATIONS AND HURDLES OF USING EMBRYONIC STEM CELLS IN TISSUE ENGINEERING;606 15.11.4;CONCLUSIONS AND FUTURE PERSPECTIVES;608 15.11.5;KEY WORDS;608 15.11.6;FURTHER READING;608 15.12;Chapter 64. Postnatal Stem Cells in Tissue Engineering;614 15.12.1;INTRODUCTION;614 15.12.2;THE RESERVOIRS OF POSTNATAL STEM CELLS;614 15.12.3;CURRENT APPROACHES TO TISSUE ENGINEERING;616 15.12.4;CONCLUSIONS;620 15.12.5;ACKNOWLEDGMENTS;621 15.12.6;KEY WORDS;621 15.12.7;FURTHER READING;621 15.13;Chapter 65. Stem Cell Gene Therapy;622 15.13.1;INTRODUCTION;622 15.13.2;GENE ADDITION;623 15.13.3;GENOME EDITING;624 15.13.4;REQUIREMENTS FOR SUCCESSFUL STEM CELL GENE THERAPY;624 15.13.5;CONCLUSION;627 15.13.6;KEY WORDS;628 15.13.7;FURTHER READING;628 16;Part VI: Regulation and Ethics;630 16.1;Chapter 66. Ethical Considerations;632 16.1.1;INTRODUCTION;632 16.1.2;IS IT MORALLY PERMISSIBLE TO DESTROY A HUMAN EMBRYO?;632 16.1.3;SHOULD WE POSTPONE HUMAN EMBRYONIC STEM CELL RESEARCH?;633 16.1.4;CAN WE BENEFIT FROM OTHERS' DESTRUCTION OF EMBRYOS?;633 16.1.5;CAN WE CREATE AN EMBRYO TO DESTROY IT?;634 16.1.6;SHOULD WE CLONE HUMAN EMBRYOS?;634 16.1.7;DOES INDUCED PLURIPOTENT STEM CELL RESEARCH ELIMINATE THE ETHICAL QUESTIONS SURROUNDING HUMAN EMBRYONIC STEM CELL RESEARCH?;635 16.1.8;WHAT ETHICAL GUIDELINES SHOULD GOVERN HUMAN EMBRYONIC STEM CELL, THERAPEUTIC CLONING, AND INDUCED PLURIPOTENT STEM CELL RESEARCH?;636 16.1.9;SUMMARY;637 16.1.10;KEY WORDS;637 16.1.11;FURTHER READING;638 16.2;Chapter 67. Stem Cell Research: Religious Considerations;640 16.2.1;INTRODUCTION;640 16.2.2;MAPPING THE TERRAIN;640 16.2.3;PARTICULAR TRADITIONS: AN OVERVIEW;642 16.2.4;ROMAN CATHOLIC CONTRIBUTIONS AND THE 14 DAY THEORY;645 16.2.5;KEY WORDS;648 16.2.6;FURTHER READING;648 16.3;Chapter 68. Stem Cell-based Therapies: Food and Drug Administration Product and Pre-Clinical Regulatory Considerations;650 16.3.1;ABSTRACT;650 16.3.2;INTRODUCTION;650 16.3.3;RESOURCES TO DEVELOP RECOMMENDATIONS FOR THE MANUFACTURE AND CHARACTE
RIZATION OF STEM CELL-BASED PRODUCTS;651 16.3.4;CRITICAL ELEMENTS FOR DEVELOPING A SAFE STEM CELL-BASED PRODUCT;652 16.3.5;GENERAL EXPECTATIONS FOR CONTROL OF THE MANUFACTURING PROCESS;657 16.3.6;PRECLINICAL EVALUATION SUPPORTS SAFETY ASSESSMENT: PROOF-OF-CONCEPT AND TOXICITY TESTING IN ANIMAL MODELS;657 16.3.7;SUMMARY;659 16.3.8;ACKNOWLEDGMENTS;660 16.3.9;KEY WORDS;660 16.3.10;FURTHER READING;660 16.4;Chapter 69. It's Not About Curiosity, It's About Cures: People Help Drive Progress;662 16.4.1;CHOOSING LIFE;662 16.4.2;SIZE OF THE PROMISE;662 16.4.3;PERSONAL PROMISES FUEL PROGRESS;663 16.4.4;HOPE VERSUS HYPE;664 16.4.5;GIVING LIFE;665 16.4.6;FRIENDS IN NEED AND DEED;665 16.4.7;PEOPLE DRIVE PROGRESS;666 16.4.8;BETTER HEALTH FOR ALL;667 17;Index;668 17.1;A;668 17.2;B;668 17.3;C;669 17.4;D;670 17.5;E;670 17.6;F;672 17.7;G;672 17.8;H;673 17.9;I;674 17.10;J;675 17.11;K;675 17.12;L;675 17.13;M;675 17.14;N;676 17.15;O;677 17.16;P;677 17.17;Q;679 17.18;R;679 17.19;S;679 17.20;T;681 17.21;U;681 17.22;V;681 17.23;W;681 17.24;X;681 17.25;Y;681 17.26;Z;681